 | • レポートコード：D0804-14618 • 出版社/出版日：GlobalInfoResearch / 2020年7月21日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、105ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、先端巨大症の世界市場を広く調査・分析し、今後の市場展望をまとめております。先端巨大症の種類別市場規模（ソマトスタチン類似体、ドーパミン作動薬、成長ホルモン受容体拮抗薬、その他）、用途別市場規模（病院、クリニック）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Novartis、Strongbridge Biopharma、Crinetics Pharmaceuticals、Aegis Therapeutics、Silence Therapeutics、Chiasma、Foresee Pharmaceuticals、Peptron、Daewoong Pharmaceutical、Amryt Pharma、Glide Pharmaceutical、Ionis Pharmaceuticals、Ipsen ・地域別グローバル市場分析 2015年-2020年 ・先端巨大症の北米市場（アメリカ、カナダ、メキシコ） ・先端巨大症のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・先端巨大症のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・先端巨大症の南米市場（ブラジル、アルゼンチン） ・先端巨大症の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：ソマトスタチン類似体、ドーパミン作動薬、成長ホルモン受容体拮抗薬、その他 ・用途別分析：病院、クリニック ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Acromegaly market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Acromegaly market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Acromegaly market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Acromegaly market has been segmented into:
Somatostatin Analogues
Dopamine Agonists
Growth Hormone Receptor Antagonists
Other
By Application, Acromegaly has been segmented into:
Hospitals
Clinics
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Acromegaly market presented in the report. This section sheds light on the sales growth of different regional and country-level Acromegaly markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Acromegaly market.
The report offers in-depth assessment of the growth and other aspects of the Acromegaly market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Acromegaly Market Share Analysis
Acromegaly competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Acromegaly sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Acromegaly sales, revenue and market share for each player covered in this report.
The major players covered in Acromegaly are:
Novartis
Strongbridge Biopharma
Crinetics Pharmaceuticals
Aegis Therapeutics
Silence Therapeutics
Chiasma
Foresee Pharmaceuticals
Peptron
Daewoong Pharmaceutical
Amryt Pharma
Glide Pharmaceutical
Ionis Pharmaceuticals
Ipsen
Table of Contents
1 Acromegaly Market Overview
1.1 Product Overview and Scope of Acromegaly
1.2 Classification of Acromegaly by Type
1.2.1 Global Acromegaly Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Acromegaly Revenue Market Share by Type in 2019
1.2.3 Somatostatin Analogues
1.2.4 Dopamine Agonists
1.2.5 Growth Hormone Receptor Antagonists
1.2.6 Other
1.3 Global Acromegaly Market by Application
1.3.1 Overview: Global Acromegaly Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.4 Global Acromegaly Market by Regions
1.4.1 Global Acromegaly Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Acromegaly (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Acromegaly Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Acromegaly Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Acromegaly Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Acromegaly Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Acromegaly Status and Prospect (2015-2025)
2 Company Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Novartis SWOT Analysis
2.1.4 Novartis Product and Services
2.1.5 Novartis Acromegaly Revenue, Gross Margin and Market Share (2018-2019)
2.2 Strongbridge Biopharma
2.2.1 Strongbridge Biopharma Details
2.2.2 Strongbridge Biopharma Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Strongbridge Biopharma SWOT Analysis
2.2.4 Strongbridge Biopharma Product and Services
2.2.5 Strongbridge Biopharma Acromegaly Revenue, Gross Margin and Market Share (2018-2019)
2.3 Crinetics Pharmaceuticals
2.3.1 Crinetics Pharmaceuticals Details
2.3.2 Crinetics Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Crinetics Pharmaceuticals SWOT Analysis
2.3.4 Crinetics Pharmaceuticals Product and Services
2.3.5 Crinetics Pharmaceuticals Acromegaly Revenue, Gross Margin and Market Share (2018-2019)
2.4 Aegis Therapeutics
2.4.1 Aegis Therapeutics Details
2.4.2 Aegis Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Aegis Therapeutics SWOT Analysis
2.4.4 Aegis Therapeutics Product and Services
2.4.5 Aegis Therapeutics Acromegaly Revenue, Gross Margin and Market Share (2018-2019)
2.5 Silence Therapeutics
2.5.1 Silence Therapeutics Details
2.5.2 Silence Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Silence Therapeutics SWOT Analysis
2.5.4 Silence Therapeutics Product and Services
2.5.5 Silence Therapeutics Acromegaly Revenue, Gross Margin and Market Share (2018-2019)
2.6 Chiasma
2.6.1 Chiasma Details
2.6.2 Chiasma Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Chiasma SWOT Analysis
2.6.4 Chiasma Product and Services
2.6.5 Chiasma Acromegaly Revenue, Gross Margin and Market Share (2018-2019)
2.7 Foresee Pharmaceuticals
2.7.1 Foresee Pharmaceuticals Details
2.7.2 Foresee Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Foresee Pharmaceuticals SWOT Analysis
2.7.4 Foresee Pharmaceuticals Product and Services
2.7.5 Foresee Pharmaceuticals Acromegaly Revenue, Gross Margin and Market Share (2018-2019)
2.8 Peptron
2.8.1 Peptron Details
2.8.2 Peptron Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Peptron SWOT Analysis
2.8.4 Peptron Product and Services
2.8.5 Peptron Acromegaly Revenue, Gross Margin and Market Share (2018-2019)
2.9 Daewoong Pharmaceutical
2.9.1 Daewoong Pharmaceutical Details
2.9.2 Daewoong Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Daewoong Pharmaceutical SWOT Analysis
2.9.4 Daewoong Pharmaceutical Product and Services
2.9.5 Daewoong Pharmaceutical Acromegaly Revenue, Gross Margin and Market Share (2018-2019)
2.10 Amryt Pharma
2.10.1 Amryt Pharma Details
2.10.2 Amryt Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Amryt Pharma SWOT Analysis
2.10.4 Amryt Pharma Product and Services
2.10.5 Amryt Pharma Acromegaly Revenue, Gross Margin and Market Share (2018-2019)
2.11 Glide Pharmaceutical
2.11.1 Glide Pharmaceutical Details
2.11.2 Glide Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Glide Pharmaceutical SWOT Analysis
2.11.4 Glide Pharmaceutical Product and Services
2.11.5 Glide Pharmaceutical Acromegaly Revenue, Gross Margin and Market Share (2018-2019)
2.12 Ionis Pharmaceuticals
2.12.1 Ionis Pharmaceuticals Details
2.12.2 Ionis Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Ionis Pharmaceuticals SWOT Analysis
2.12.4 Ionis Pharmaceuticals Product and Services
2.12.5 Ionis Pharmaceuticals Acromegaly Revenue, Gross Margin and Market Share (2018-2019)
2.13 Ipsen
2.13.1 Ipsen Details
2.13.2 Ipsen Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Ipsen SWOT Analysis
2.13.4 Ipsen Product and Services
2.13.5 Ipsen Acromegaly Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Acromegaly Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Acromegaly Players Market Share
3.2.2 Top 10 Acromegaly Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Acromegaly Revenue and Market Share by Regions
4.2 North America Acromegaly Revenue and Growth Rate (2015-2020)
4.3 Europe Acromegaly Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Acromegaly Revenue and Growth Rate (2015-2020)
4.5 South America Acromegaly Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Acromegaly Revenue and Growth Rate (2015-2020)
5 North America Acromegaly Revenue by Countries
5.1 North America Acromegaly Revenue by Countries (2015-2020)
5.2 USA Acromegaly Revenue and Growth Rate (2015-2020)
5.3 Canada Acromegaly Revenue and Growth Rate (2015-2020)
5.4 Mexico Acromegaly Revenue and Growth Rate (2015-2020)
6 Europe Acromegaly Revenue by Countries
6.1 Europe Acromegaly Revenue by Countries (2015-2020)
6.2 Germany Acromegaly Revenue and Growth Rate (2015-2020)
6.3 UK Acromegaly Revenue and Growth Rate (2015-2020)
6.4 France Acromegaly Revenue and Growth Rate (2015-2020)
6.5 Russia Acromegaly Revenue and Growth Rate (2015-2020)
6.6 Italy Acromegaly Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Acromegaly Revenue by Countries
7.1 Asia-Pacific Acromegaly Revenue by Countries (2015-2020)
7.2 China Acromegaly Revenue and Growth Rate (2015-2020)
7.3 Japan Acromegaly Revenue and Growth Rate (2015-2020)
7.4 Korea Acromegaly Revenue and Growth Rate (2015-2020)
7.5 India Acromegaly Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Acromegaly Revenue and Growth Rate (2015-2020)
8 South America Acromegaly Revenue by Countries
8.1 South America Acromegaly Revenue by Countries (2015-2020)
8.2 Brazil Acromegaly Revenue and Growth Rate (2015-2020)
8.3 Argentina Acromegaly Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Acromegaly by Countries
9.1 Middle East & Africa Acromegaly Revenue by Countries (2015-2020)
9.2 Saudi Arabia Acromegaly Revenue and Growth Rate (2015-2020)
9.3 UAE Acromegaly Revenue and Growth Rate (2015-2020)
9.4 Egypt Acromegaly Revenue and Growth Rate (2015-2020)
9.5 South Africa Acromegaly Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Acromegaly Revenue and Market Share by Type (2015-2020)
10.2 Global Acromegaly Market Forecast by Type (2019-2024)
10.3 Somatostatin Analogues Revenue Growth Rate (2015-2025)
10.4 Dopamine Agonists Revenue Growth Rate (2015-2025)
10.5 Growth Hormone Receptor Antagonists Revenue Growth Rate (2015-2025)
10.6 Other Revenue Growth Rate (2015-2025)
11 Global Acromegaly Market Segment by Application
11.1 Global Acromegaly Revenue Market Share by Application (2015-2020)
11.2 Acromegaly Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Clinics Revenue Growth (2015-2020)
12 Global Acromegaly Market Size Forecast (2021-2025)
12.1 Global Acromegaly Market Size Forecast (2021-2025)
12.2 Global Acromegaly Market Forecast by Regions (2021-2025)
12.3 North America Acromegaly Revenue Market Forecast (2021-2025)
12.4 Europe Acromegaly Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Acromegaly Revenue Market Forecast (2021-2025)
12.6 South America Acromegaly Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Acromegaly Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Acromegaly Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Acromegaly by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Acromegaly Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Acromegaly Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Novartis Corporate Information, Location and Competitors
Table 6. Novartis Acromegaly Major Business
Table 7. Novartis Acromegaly Total Revenue (USD Million) (2017-2018)
Table 8. Novartis SWOT Analysis
Table 9. Novartis Acromegaly Product and Solutions
Table 10. Novartis Acromegaly Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Strongbridge Biopharma Corporate Information, Location and Competitors
Table 12. Strongbridge Biopharma Acromegaly Major Business
Table 13. Strongbridge Biopharma Acromegaly Total Revenue (USD Million) (2018-2019)
Table 14. Strongbridge Biopharma SWOT Analysis
Table 15. Strongbridge Biopharma Acromegaly Product and Solutions
Table 16. Strongbridge Biopharma Acromegaly Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Crinetics Pharmaceuticals Corporate Information, Location and Competitors
Table 18. Crinetics Pharmaceuticals Acromegaly Major Business
Table 19. Crinetics Pharmaceuticals Acromegaly Total Revenue (USD Million) (2017-2018)
Table 20. Crinetics Pharmaceuticals SWOT Analysis
Table 21. Crinetics Pharmaceuticals Acromegaly Product and Solutions
Table 22. Crinetics Pharmaceuticals Acromegaly Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Aegis Therapeutics Corporate Information, Location and Competitors
Table 24. Aegis Therapeutics Acromegaly Major Business
Table 25. Aegis Therapeutics Acromegaly Total Revenue (USD Million) (2017-2018)
Table 26. Aegis Therapeutics SWOT Analysis
Table 27. Aegis Therapeutics Acromegaly Product and Solutions
Table 28. Aegis Therapeutics Acromegaly Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Silence Therapeutics Corporate Information, Location and Competitors
Table 30. Silence Therapeutics Acromegaly Major Business
Table 31. Silence Therapeutics Acromegaly Total Revenue (USD Million) (2017-2018)
Table 32. Silence Therapeutics SWOT Analysis
Table 33. Silence Therapeutics Acromegaly Product and Solutions
Table 34. Silence Therapeutics Acromegaly Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Chiasma Corporate Information, Location and Competitors
Table 36. Chiasma Acromegaly Major Business
Table 37. Chiasma Acromegaly Total Revenue (USD Million) (2017-2018)
Table 38. Chiasma SWOT Analysis
Table 39. Chiasma Acromegaly Product and Solutions
Table 40. Chiasma Acromegaly Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Foresee Pharmaceuticals Corporate Information, Location and Competitors
Table 42. Foresee Pharmaceuticals Acromegaly Major Business
Table 43. Foresee Pharmaceuticals Acromegaly Total Revenue (USD Million) (2017-2018)
Table 44. Foresee Pharmaceuticals SWOT Analysis
Table 45. Foresee Pharmaceuticals Acromegaly Product and Solutions
Table 46. Foresee Pharmaceuticals Acromegaly Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Peptron Corporate Information, Location and Competitors
Table 48. Peptron Acromegaly Major Business
Table 49. Peptron Acromegaly Total Revenue (USD Million) (2017-2018)
Table 50. Peptron SWOT Analysis
Table 51. Peptron Acromegaly Product and Solutions
Table 52. Peptron Acromegaly Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Daewoong Pharmaceutical Corporate Information, Location and Competitors
Table 54. Daewoong Pharmaceutical Acromegaly Major Business
Table 55. Daewoong Pharmaceutical Acromegaly Total Revenue (USD Million) (2017-2018)
Table 56. Daewoong Pharmaceutical SWOT Analysis
Table 57. Daewoong Pharmaceutical Acromegaly Product and Solutions
Table 58. Daewoong Pharmaceutical Acromegaly Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Amryt Pharma Corporate Information, Location and Competitors
Table 60. Amryt Pharma Acromegaly Major Business
Table 61. Amryt Pharma Acromegaly Total Revenue (USD Million) (2017-2018)
Table 62. Amryt Pharma SWOT Analysis
Table 63. Amryt Pharma Acromegaly Product and Solutions
Table 64. Amryt Pharma Acromegaly Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Glide Pharmaceutical Corporate Information, Location and Competitors
Table 66. Glide Pharmaceutical Acromegaly Major Business
Table 67. Glide Pharmaceutical Acromegaly Total Revenue (USD Million) (2017-2018)
Table 68. Glide Pharmaceutical SWOT Analysis
Table 69. Glide Pharmaceutical Acromegaly Product and Solutions
Table 70. Glide Pharmaceutical Acromegaly Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Ionis Pharmaceuticals Corporate Information, Location and Competitors
Table 72. Ionis Pharmaceuticals Acromegaly Major Business
Table 73. Ionis Pharmaceuticals Acromegaly Total Revenue (USD Million) (2017-2018)
Table 74. Ionis Pharmaceuticals SWOT Analysis
Table 75. Ionis Pharmaceuticals Acromegaly Product and Solutions
Table 76. Ionis Pharmaceuticals Acromegaly Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Ipsen Corporate Information, Location and Competitors
Table 78. Ipsen Acromegaly Major Business
Table 79. Ipsen Acromegaly Total Revenue (USD Million) (2017-2018)
Table 80. Ipsen SWOT Analysis
Table 81. Ipsen Acromegaly Product and Solutions
Table 82. Ipsen Acromegaly Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Global Acromegaly Revenue (Million USD) by Players (2015-2020)
Table 84. Global Acromegaly Revenue Share by Players (2015-2020)
Table 85. Global Acromegaly Revenue (Million USD) by Regions (2015-2020)
Table 86. Global Acromegaly Revenue Market Share by Regions (2015-2020)
Table 87. North America Acromegaly Revenue by Countries (2015-2020)
Table 88. North America Acromegaly Revenue Market Share by Countries (2015-2020)
Table 89. Europe Acromegaly Revenue (Million USD) by Countries (2015-2020)
Table 90. Asia-Pacific Acromegaly Revenue (Million USD) by Countries (2015-2020)
Table 91. South America Acromegaly Revenue by Countries (2015-2020)
Table 92. South America Acromegaly Revenue Market Share by Countries (2015-2020)
Table 93. Middle East and Africa Acromegaly Revenue (Million USD) by Countries (2015-2020)
Table 94. Middle East and Africa Acromegaly Revenue Market Share by Countries (2015-2020)
Table 95. Global Acromegaly Revenue (Million USD) by Type (2015-2020)
Table 96. Global Acromegaly Revenue Share by Type (2015-2020)
Table 97. Global Acromegaly Revenue Forecast by Type (2021-2025)
Table 98. Global Acromegaly Revenue by Application (2015-2020)
Table 99. Global Acromegaly Revenue Share by Application (2015-2020)
Table 100. Global Acromegaly Revenue Forecast by Application (2021-2025)
Table 101. Global Acromegaly Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Acromegaly Picture
Figure 2. Global Acromegaly Revenue Market Share by Type in 2019
Figure 3. Somatostatin Analogues Picture
Figure 4. Dopamine Agonists Picture
Figure 5. Growth Hormone Receptor Antagonists Picture
Figure 6. Other Picture
Figure 7. Acromegaly Revenue Market Share by Application in 2019
Figure 8. Hospitals Picture
Figure 9. Clinics Picture
Figure 10. Global Acromegaly Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Acromegaly Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Acromegaly Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Acromegaly Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Acromegaly Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Acromegaly Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Acromegaly Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Acromegaly Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Acromegaly Revenue Market Share in 2019
Figure 19. Global Top 10 Players Acromegaly Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Acromegaly Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Acromegaly Revenue Market Share by Regions (2015-2020)
Figure 23. Global Acromegaly Revenue Market Share by Regions in 2018
Figure 24. North America Acromegaly Revenue and Growth Rate (2015-2020)
Figure 25. Europe Acromegaly Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Acromegaly Revenue and Growth Rate (2015-2020)
Figure 27. South America Acromegaly Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Acromegaly Revenue and Growth Rate (2015-2020)
Figure 29. North America Acromegaly Revenue Market Share by Countries (2015-2020)
Figure 30. North America Acromegaly Revenue Market Share by Countries in 2019
Figure 31. USA Acromegaly Revenue and Growth Rate (2015-2020)
Figure 32. Canada Acromegaly Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Acromegaly Revenue and Growth Rate (2015-2020)
Figure 34. Europe Acromegaly Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Acromegaly Revenue Market Share by Countries in 2019
Figure 36. Germany Acromegaly Revenue and Growth Rate (2015-2020)
Figure 37. UK Acromegaly Revenue and Growth Rate (2015-2020)
Figure 38. France Acromegaly Revenue and Growth Rate (2015-2020)
Figure 39. Russia Acromegaly Revenue and Growth Rate (2015-2020)
Figure 40. Italy Acromegaly Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Acromegaly Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific Acromegaly Revenue Market Share by Countries in 2019
Figure 43. China Acromegaly Revenue and Growth Rate (2015-2020)
Figure 44. Japan Acromegaly Revenue and Growth Rate (2015-2020)
Figure 45. Korea Acromegaly Revenue and Growth Rate (2015-2020)
Figure 46. India Acromegaly Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Acromegaly Revenue and Growth Rate (2015-2020)
Figure 48. South America Acromegaly Revenue Market Share by Countries (2015-2020)
Figure 49. South America Acromegaly Revenue Market Share by Countries in 2019
Figure 50. Brazil Acromegaly Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Acromegaly Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Acromegaly Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Acromegaly Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Acromegaly Revenue and Growth Rate (2015-2020)
Figure 55. UAE Acromegaly Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Acromegaly Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Acromegaly Revenue and Growth Rate (2015-2020)
Figure 58. Global Acromegaly Revenue Share by Type (2015-2020)
Figure 59. Global Acromegaly Revenue Share by Type in 2019
Figure 60. Global Acromegaly Market Share Forecast by Type (2021-2025)
Figure 61. Global Somatostatin Analogues Revenue Growth Rate (2015-2020)
Figure 62. Global Dopamine Agonists Revenue Growth Rate (2015-2020)
Figure 63. Global Growth Hormone Receptor Antagonists Revenue Growth Rate (2015-2020)
Figure 64. Global Other Revenue Growth Rate (2015-2020)
Figure 65. Global Acromegaly Revenue Share by Application (2015-2020)
Figure 66. Global Acromegaly Revenue Share by Application in 2019
Figure 67. Global Acromegaly Market Share Forecast by Application (2021-2025)
Figure 68. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 69. Global Clinics Revenue Growth Rate (2015-2020)
Figure 70. Global Acromegaly Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Acromegaly Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Acromegaly Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Acromegaly Revenue Market Forecast (2021-2025)
Figure 74. Europe Acromegaly Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Acromegaly Revenue Market Forecast (2021-2025)
Figure 76. South America Acromegaly Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Acromegaly Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
AT1受容体拮抗薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global AT1 Receptor Antagonists market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The AT1 Receptor Antagon…- AT1受容体拮抗薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global AT1 Receptor Antagonists market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The AT1 Receptor Antagon…
- アンジオテンシン受容体拮抗薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Angiotensin Receptor Antagonists market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Angiotensin …
- スフィンゴシン1-リン酸受容体1の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Sphingosine 1-Phosphate Receptor 1 market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain …
- 経口血糖降下薬及びインスリン類似体の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Oral Hypoglycemic Agents and Insulin Analogues market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. Th…